The defence sector’s shifting landscape is creating a stark divergence at Hensoldt. While the company’s order book swells and its chief executive puts his own money on the line, an external force from across the Channel is dragging the stock lower.
Oliver Dörre, Hensoldt’s CEO, purchased 2,500 shares on Monday at a cost of roughly €172,000, executed via Xetra and the Stuttgart exchange. Insider transactions of this kind are closely watched as a gauge of management conviction — executives rarely deploy personal capital unless they see a clear path to value creation. The move comes at a time when the company’s operational momentum could hardly be stronger.
Yet by Wednesday, the shares had tumbled 4.82% to €67.90, inching closer to the 52-week low of €64.80. The trigger lies not in any company-specific setback but in the approaching initial public offering of KNDS, the Franco-German defence heavyweight. KNDS is preparing to list on the Paris and Frankfurt exchanges, with existing shareholders placing roughly 20% of their stakes. The offering is limited to institutional investors, leaving retail buyers on the sidelines.
The knock-on effect is clear: large funds are reshuffling their portfolios to make room for a new European defence name that arrives with imposing credentials. KNDS reported an order backlog of €33.1 billion at the end of 2025. Adding to the pressure, the German government is planning a major entry via KfW, which is set to acquire 40% of KNDS shares — a move contingent on a successful market debut. The political backing for this rival is formidable.
Hensoldt’s own fundamentals, by contrast, could hardly be more compelling. The company recorded a record order intake in the first quarter, with incoming orders nearly doubling to €1.5 billion. The total order backlog hit an all-time high of €9.8 billion, ensuring factory utilisation is secured for years. Accelerated domestic procurement processes are fuelling the momentum.
Should investors sell immediately? Or is it worth buying Hensoldt?
In early June, management raised the free cash flow guidance, now targeting a conversion rate of 50% of operating profit, up from 40%. Higher customer prepayments are boosting liquidity, providing greater financial flexibility. The net leverage target of 1.5 times remains unchanged, underscoring a disciplined balance sheet strategy.
Analysts see substantial upside from current levels. The average price target stands at around €90, while Morningstar assigns a fair value of €110 — more than 60% above Wednesday’s close. The disconnect between market sentiment and operating reality has widened to an unusual degree.
Hensoldt shares have lost nearly a quarter of their value over the past 30 days, and the distance to the 200-day moving line has stretched beyond 17%. Year to date, the stock is down roughly a fifth, with sideways movement since January. The company’s next scheduled catalyst is the half-year results on 31 July, and until then the KNDS narrative is likely to dominate the European defence conversation.
In the meantime, Dörre’s €172,000 wager stands as a quiet counterpoint to the noise — a bet that the market’s focus will eventually swing back to Hensoldt’s record backlog and rising cash generation.
Ad
Hensoldt Stock: Buy or Sell?! New Hensoldt Analysis from June 24 delivers the answer:
The latest Hensoldt figures speak for themselves: Urgent action needed for Hensoldt investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from June 24.
Hensoldt: Buy or sell? Read more here...
